Glucotrack Completes Business Combination with Lōkahi Therapeutics to Form AI-Driven Healthcare Platform
Glucotrack has completed its business combination with Lōkahi Therapeutics, forming a publicly traded healthcare platform focused on acquiring and developing assets using an AI-driven approach. The transaction results in Lōkahi shareholders owning approximately 90% of the combined company post-conversion.
Tickers: $GCTK